Newsletter Subscription


Saturday, Dec 10, 2016


Implant Sciences Sells QS-B220 Explosives Trace Detectors for use at 19 Airports

  • QS-B220 becomes the adopted standard for explosives trace detection equipment at a number of major airports in Latin American country

Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today that its QS-B220 explosives trace detectors have been sold to a federal agency in charge of operating 19 airports in one Latin American country.  The units will be used for checkpoint screening and air cargo screening.

"With this deployment, our QS-B220 has become the system of choice in explosives trace detection devices for these 19 airports. This is a major milestone for Implant Sciences and gives the Company a significant presence in the Latin American aviation security market," stated Implant Sciences' Vice President of Sales and Marketing, Dr. Darryl Jones. "The QS-B220 was selected based on its favorable total cost of ownership, superior performance capabilities, and its regulatory certifications."


Related Research on ASDReports.com:
Military Satellites Market Report 2016-2026

Source : Implant Sciences Corporation

Published on ASDNews: Nov 6, 2013

 

Future Soldier Technology Conference

Mar 13 - 14, 2017 - London, United Kingdom

Register More info


Biometrics for Government & Law Enforcement Summit

Jan 23 - 25, 2017 - Arlington, United States

Register More info


© 2004-2016 • ASDNews • be the first to know • contact usterms & conditionsprivacy policyadvertisingfaqs

zpsk